
Sign up to save your podcasts
Or


Dr Zylke provides summary and commentary on the March 28, 2012 issue of JAMA, the Journal of the American Medical Association. Imatinib for Gastrointestinal Stromal Tumor, Cardiovascular Health Metrics and Mortality, Asthma Medication Costs and Health Care Use, Myotonic Dystrophy and Conduction System Disease, Lipids, Cardiovascular Events, and Statin Therapy, Are medical conferences useful?, Innovative health care models and financing.
By JAMA Network3.9
126126 ratings
Dr Zylke provides summary and commentary on the March 28, 2012 issue of JAMA, the Journal of the American Medical Association. Imatinib for Gastrointestinal Stromal Tumor, Cardiovascular Health Metrics and Mortality, Asthma Medication Costs and Health Care Use, Myotonic Dystrophy and Conduction System Disease, Lipids, Cardiovascular Events, and Statin Therapy, Are medical conferences useful?, Innovative health care models and financing.

319 Listeners

698 Listeners

496 Listeners

168 Listeners

885 Listeners

295 Listeners

3,345 Listeners

1,148 Listeners

193 Listeners

92 Listeners

513 Listeners

369 Listeners

247 Listeners

424 Listeners

373 Listeners